Rafa Laboratories lands $186 million BARDA contract to develop life-saving trauma drug
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
The multibillion-dollar Maryland expansion is part of AstraZeneca’s sweeping $50 billion global investment plan
The drug is being tested for combined post- and precapillary pulmonary hypertension due to heart failure with preserved ejection fraction
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
Subscribe To Our Newsletter & Stay Updated